Coronavirus drug trial recruiting over 50s rolls out across the UK

People over the age of 50 are invited to take part in a potential coronavirus drug trial
REUTERS

Researchers are looking to recruit over 50s who are vulnerable to developing serious symptoms for a coronavirus drug trial.

More than 500 GP surgeries across the UK are asking people aged over 50 or 65, who have a new, continuous cough or high temperature for fewer than 15 days, to test pre-existing drugs.

Patients with an underlying health condition are invited to fill out an online questionnaire at home to see if they are eligible for the trial. They can also contact participating GPs to see if they are suitable.

Led by an Oxford University team, the Platform Randomised trial of Interventions against Covid-19 in older People (Principle) aims to slow or halt the progression of the virus and prevent the need for hospital admission.

The treatment trial is the first to take place in primary care, and one of the Government’s four national priority platform trials on the disease.

Principle is trialling a number of low-risk treatments recommended by an expert panel advising the chief medical officer for England.

In the first phase, it is evaluating whether a seven-day course of hydroxychloroquine, a well-known drug used for acute malaria and certain types of arthritis, can reduce the severity of symptoms in vulnerable groups and help avoid hospital admission.

People aged over 50 or 65 are invited to take part in the drug trial 
via REUTERS

The antibiotic azithromycin will soon be added to the trial.

Chris Butler, professor of primary care in the Nuffield Department of Primary Care Health Sciences, is a part-time GP for the Cwm Taf Morgannwg University Health Board, Fellow of Trinity College, and chief investigator of the trial.

He said: “The Principle trial platform is enabling us to rapidly evaluate potential treatments for Covid-19 in older people who are most at risk of serious complications from the illness.

“With enough people recruited, this trial will give us the vital information we need to understand whether existing drugs can help people recover sooner and at home, without needing to be admitted to hospital – a significant milestone in the course of this pandemic.

Coronavirus infecting a cell - In pictures

1/7

“As soon as we find that any one of the drugs in our trial is making a critical difference to people’s health, we want it to be part of clinical practice as soon as it can be introduced.”

Chief medical officer Professor Chris Whitty added: “The Government is working with researchers to find proven, effective treatments for Covid-19.

“This Principle trial is a vital part of this research effort and it’s being scaled up by GP surgeries across the country.

“I would urge anyone who is contacted to take part in this trial to do so and contribute to helping our world-class scientists find a treatment that will save lives.”

Participants will be closely monitored for the first 28 days of the trial, with a health record notes review taking place for up to three months.

This will allow researchers to understand the longer-term effects of the illness on participants’ health.

People are eligible to join the trial if they are aged 50-64 with a pre-existing illness such as high blood pressure and/or heart disease, asthma or lung disease, a weakened immune system, diabetes not treated with insulin, stroke or neurological problems, or liver disease.

They may also be eligible if they are aged 65 and above.

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Create Account you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy policy .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in